Carillion looks to sell its UK Healthcare arm

By Catherine Sturman
Share
Construction giant Carillion has been struggling for some time, yet this is set to change. With losses of over £1 billion in just six months, the compa...

Construction giant Carillion has been struggling for some time, yet this is set to change. With losses of over £1 billion in just six months, the company has been rumoured to be selling off its UK healthcare business after increased interest from potential investors who view its long-term potential.

At present, the company is a leader in facilities management for the National Health Service, leading to a large number of proposals from potential investors. It has been stated that the company aims to receive over £300 million for a potential sale.

Related stories

“The Board of Carillion confirms that, consistent with Carillion’s announcement on 29 September 2017, it has received proposals from more than one credible counterparty for a possible acquisition of that business,” the company said.

“A further announcement will be made as and when appropriate.”

At present, the company is removing itself from all public-private partnership deals, but is continuing to work on the development of hospital facilities globally. However, staff shortages are responsible for ongoing delays to such construction works.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma